Detalhe da pesquisa
1.
Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease.
Cell
; 183(6): 1699-1713.e13, 2020 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33188775
2.
Peripheral Aß acts as a negative modulator of insulin secretion.
Proc Natl Acad Sci U S A
; 119(12): e2117723119, 2022 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35290109
3.
Gene-gene functional relationships in Alzheimer's disease: CELF1 regulates KLC1 alternative splicing.
Biochem Biophys Res Commun
; 721: 150025, 2024 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768546
4.
Novel pathophysiological roles of α-synuclein in age-related vascular endothelial dysfunction.
FASEB J
; 36(10): e22555, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125010
5.
Antiepileptic Drugs Modulate Alzheimer-Related Tau Aggregation in a Neuronal Activity-Independent Manner.
Dement Geriatr Cogn Disord
; 52(2): 108-116, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878194
6.
Increased levels of Aß42 decrease the lifespan of ob/ob mice with dysregulation of microglia and astrocytes.
FASEB J
; 34(2): 2425-2435, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31907998
7.
Novel properties of myoferlin in glucose metabolism via pathways involving modulation of adipose functions.
FASEB J
; 34(2): 2792-2811, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31912559
8.
Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity.
EMBO J
; 34(24): 3028-41, 2015 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26538322
9.
Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro.
Am J Pathol
; 187(6): 1399-1412, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28408124
10.
Secretion and Uptake of α-Synuclein Via Extracellular Vesicles in Cultured Cells.
Cell Mol Neurobiol
; 38(8): 1539-1550, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30288631
11.
Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients.
Ann Neurol
; 80(3): 355-67, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27351289
12.
A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid ß in the brain in a transgenic model of Alzheimer disease.
J Biol Chem
; 290(4): 1966-78, 2015 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25468905
13.
Formation, release, and internalization of stable tau oligomers in cells.
J Neurochem
; 139(6): 1163-1174, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27731899
14.
Oxidative stress and lipid peroxidation are upstream of amyloid pathology.
Neurobiol Dis
; 84: 109-19, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26102023
15.
Brain interstitial oligomeric amyloid ß increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease.
FASEB J
; 27(8): 3239-48, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23640054
16.
Imaging Biomarker for Early-Stage Alzheimer Disease: Utility of Hippocampal Histogram Analysis of Diffusion Metrics.
AJNR Am J Neuroradiol
; 45(3): 320-327, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331963
17.
Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid ß peptide.
J Neurosci
; 32(43): 15181-92, 2012 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23100439
18.
Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes.
Proc Natl Acad Sci U S A
; 107(15): 7036-41, 2010 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-20231468
19.
RGMa collapses the neuronal actin barrier against disease-implicated protein and exacerbates ALS.
Sci Adv
; 9(47): eadg3193, 2023 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37992159
20.
Oral glucose loading modulates plasma ß-amyloid level in alzheimer's disease patients: potential diagnostic method for Alzheimer's disease.
Dement Geriatr Cogn Disord
; 34(1): 25-30, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22889768